0

Close
 
Upcoming Allied Market Research
2023
Demineralized Bone Matrix Market

Demineralized Bone Matrix Market

by Type (Allograft, Autograft) and by Applications (Joint, Dental, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A02367
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Demineralized Bone Matrix Market

Request Now !

Demineralized bone matrix (DBM) is an allograft bone from which the inorganic mineral is removed and leaves behind collagen (structural protein) matrix. The removal of the bone mineral further results in exposing more biologically active bone morphogenetic proteins (growth factors). Further, demineralized bone matrix is used to extend and bolster the bone graft. This is due to the ability of growth factors to control the differentiation of progenitor cells, which are responsible for bone and cartilage formation.

Hence, demineralized bone matrix (DBM) is more biologically active as compared to mineralized bone grafts and aids in bone generation. The demineralized bone matrix market is expected to grow rapidly owing to the advancements and innovations in the field of grafting and the sudden surge in cosmetic surgery. In addition, the increase in soft tissue allograft and increase in demand of surgical procedures for younger generation and athletics will certainly result in the growth of this market.

Further, the high cost of bone grafting and minimal awareness among the population especially in the developing countries such as China, India, Brazil, and others impede the growth of the demineralized bone matrix market.

The global demineralized bone matrix market is segmented based on type, applications, and region. Based on type, the market is bifurcated into allograft and autograft bone grafting. Based on applications, it is classified into joint, dental, and other. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as NovaBone Products, Zimmer Biomet, Exactech, Inc., AlloSource, LifeNet Health, Inc., Smith & Nephew., DePuy Synthes Companies, Medtronic plc, Wright Medical Group and Baxter International, Inc. is also provided in this report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global demineralized bone matrix market.
  • In-depth analysis is conducted by constructing market estimations for the key market segments.
  • This study evaluates the competitive landscape and value chain is taken into account to help understand the competitive environment across the geographies.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • This report provides the quantitative analysis of the current market and estimations which assists in identifying the prevailing market opportunities

 Demineralized Bone Matrix Market Report Highlights

Aspects Details
By Type
  • Allograft
  • Autograft
By Applications
  • Joint
  • Dental
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Wright Medical Group, Exactech, Inc., LifeNet Health, Inc., Smith & Nephew, NovaBone Products, Medtronic plc., Zimmer Biomet, DePuy Synthes Companies, AlloSource, Baxter International
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: DEMINERALIZED BONE MATRIX MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Allograft

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Autograft

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: DEMINERALIZED BONE MATRIX MARKET, BY APPLICATIONS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Applications

    • 5.2. Joint

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Dental

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: DEMINERALIZED BONE MATRIX MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Applications

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Demineralized Bone Matrix Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Applications

      • 6.2.6. Canada Demineralized Bone Matrix Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Applications

      • 6.2.7. Mexico Demineralized Bone Matrix Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Applications

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Applications

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Demineralized Bone Matrix Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Applications

      • 6.3.6. Germany Demineralized Bone Matrix Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Applications

      • 6.3.7. Italy Demineralized Bone Matrix Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Applications

      • 6.3.8. Spain Demineralized Bone Matrix Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Applications

      • 6.3.9. UK Demineralized Bone Matrix Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Applications

      • 6.3.10. Russia Demineralized Bone Matrix Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Applications

      • 6.3.11. Rest Of Europe Demineralized Bone Matrix Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Applications

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Applications

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Demineralized Bone Matrix Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Applications

      • 6.4.6. Japan Demineralized Bone Matrix Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Applications

      • 6.4.7. India Demineralized Bone Matrix Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Applications

      • 6.4.8. South Korea Demineralized Bone Matrix Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Applications

      • 6.4.9. Australia Demineralized Bone Matrix Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Applications

      • 6.4.10. Thailand Demineralized Bone Matrix Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Applications

      • 6.4.11. Malaysia Demineralized Bone Matrix Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Applications

      • 6.4.12. Indonesia Demineralized Bone Matrix Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Applications

      • 6.4.13. Rest of Asia Pacific Demineralized Bone Matrix Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Applications

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Applications

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Demineralized Bone Matrix Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Applications

      • 6.5.6. South Africa Demineralized Bone Matrix Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Applications

      • 6.5.7. Saudi Arabia Demineralized Bone Matrix Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Applications

      • 6.5.8. UAE Demineralized Bone Matrix Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Applications

      • 6.5.9. Argentina Demineralized Bone Matrix Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Applications

      • 6.5.10. Rest of LAMEA Demineralized Bone Matrix Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Applications

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. NovaBone Products

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Zimmer Biomet

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Exactech, Inc.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. AlloSource

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. LifeNet Health, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Smith And Nephew

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. DePuy Synthes Companies

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Medtronic Plc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Wright Medical Group

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Baxter International

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR ALLOGRAFT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR AUTOGRAFT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR JOINT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR DENTAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA DEMINERALIZED BONE MATRIX, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 12. U.S. DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. U.S. DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 14. CANADA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. CANADA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE DEMINERALIZED BONE MATRIX, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 21. FRANCE DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. FRANCE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. GERMANY DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 25. ITALY DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. ITALY DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 29. UK DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. UK DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 31. RUSSIA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. RUSSIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC DEMINERALIZED BONE MATRIX, BY REGION, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 38. CHINA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. CHINA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 42. INDIA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. INDIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 48. THAILAND DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. THAILAND DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 50. MALAYSIA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. MALAYSIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 52. INDONESIA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. INDONESIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 56. LAMEA DEMINERALIZED BONE MATRIX, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. LAMEA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 59. BRAZIL DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. BRAZIL DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 61. SOUTH AFRICA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH AFRICA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 63. SAUDI ARABIA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SAUDI ARABIA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 65. UAE DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. UAE DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 67. ARGENTINA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. ARGENTINA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 69. REST OF LAMEA DEMINERALIZED BONE MATRIX, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF LAMEA DEMINERALIZED BONE MATRIX, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 71. NOVABONE PRODUCTS: KEY EXECUTIVES
  • TABLE 72. NOVABONE PRODUCTS: COMPANY SNAPSHOT
  • TABLE 73. NOVABONE PRODUCTS: OPERATING SEGMENTS
  • TABLE 74. NOVABONE PRODUCTS: PRODUCT PORTFOLIO
  • TABLE 75. NOVABONE PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. ZIMMER BIOMET: KEY EXECUTIVES
  • TABLE 77. ZIMMER BIOMET: COMPANY SNAPSHOT
  • TABLE 78. ZIMMER BIOMET: OPERATING SEGMENTS
  • TABLE 79. ZIMMER BIOMET: PRODUCT PORTFOLIO
  • TABLE 80. ZIMMER BIOMET: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. EXACTECH, INC.: KEY EXECUTIVES
  • TABLE 82. EXACTECH, INC.: COMPANY SNAPSHOT
  • TABLE 83. EXACTECH, INC.: OPERATING SEGMENTS
  • TABLE 84. EXACTECH, INC.: PRODUCT PORTFOLIO
  • TABLE 85. EXACTECH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. ALLOSOURCE: KEY EXECUTIVES
  • TABLE 87. ALLOSOURCE: COMPANY SNAPSHOT
  • TABLE 88. ALLOSOURCE: OPERATING SEGMENTS
  • TABLE 89. ALLOSOURCE: PRODUCT PORTFOLIO
  • TABLE 90. ALLOSOURCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. LIFENET HEALTH, INC.: KEY EXECUTIVES
  • TABLE 92. LIFENET HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 93. LIFENET HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 94. LIFENET HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 95. LIFENET HEALTH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 97. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 98. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 99. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 100. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. DEPUY SYNTHES COMPANIES: KEY EXECUTIVES
  • TABLE 102. DEPUY SYNTHES COMPANIES: COMPANY SNAPSHOT
  • TABLE 103. DEPUY SYNTHES COMPANIES: OPERATING SEGMENTS
  • TABLE 104. DEPUY SYNTHES COMPANIES: PRODUCT PORTFOLIO
  • TABLE 105. DEPUY SYNTHES COMPANIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 107. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 108. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 109. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 110. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. WRIGHT MEDICAL GROUP: KEY EXECUTIVES
  • TABLE 112. WRIGHT MEDICAL GROUP: COMPANY SNAPSHOT
  • TABLE 113. WRIGHT MEDICAL GROUP: OPERATING SEGMENTS
  • TABLE 114. WRIGHT MEDICAL GROUP: PRODUCT PORTFOLIO
  • TABLE 115. WRIGHT MEDICAL GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. BAXTER INTERNATIONAL: KEY EXECUTIVES
  • TABLE 117. BAXTER INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 118. BAXTER INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 119. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 120. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DEMINERALIZED BONE MATRIX MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 3. SEGMENTATION DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDEMINERALIZED BONE MATRIX MARKET
  • FIGURE 11. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. DEMINERALIZED BONE MATRIX MARKET FOR ALLOGRAFT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. DEMINERALIZED BONE MATRIX MARKET FOR AUTOGRAFT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION, BY BY APPLICATIONS
  • FIGURE 15. DEMINERALIZED BONE MATRIX MARKET FOR JOINT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. DEMINERALIZED BONE MATRIX MARKET FOR DENTAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. DEMINERALIZED BONE MATRIX MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: DEMINERALIZED BONE MATRIX MARKET
  • FIGURE 24. Top player positioning, 2022
  • FIGURE 25. NOVABONE PRODUCTS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 26. NOVABONE PRODUCTS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 27. NOVABONE PRODUCTS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 28. ZIMMER BIOMET: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. EXACTECH, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. EXACTECH, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. EXACTECH, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. ALLOSOURCE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. ALLOSOURCE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. ALLOSOURCE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. LIFENET HEALTH, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. LIFENET HEALTH, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. LIFENET HEALTH, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. SMITH AND NEPHEW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. DEPUY SYNTHES COMPANIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. DEPUY SYNTHES COMPANIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. DEPUY SYNTHES COMPANIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. MEDTRONIC PLC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. WRIGHT MEDICAL GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. WRIGHT MEDICAL GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. WRIGHT MEDICAL GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. BAXTER INTERNATIONAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. BAXTER INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. BAXTER INTERNATIONAL: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Demineralized Bone Matrix Market

Start reading.
This Report and over 68,439+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers